Centene Co. (NYSE:CNC) Stake Boosted by Mn Services Vermogensbeheer B.V.

Mn Services Vermogensbeheer B.V. lifted its holdings in Centene Co. (NYSE:CNC) by 1.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 208,300 shares of the company’s stock after buying an additional 3,400 shares during the quarter. Mn Services Vermogensbeheer B.V.’s holdings in Centene were worth $12,619,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Capital Advisors Ltd. LLC raised its position in shares of Centene by 75.3% during the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock worth $25,000 after purchasing an additional 177 shares during the period. Private Trust Co. NA lifted its stake in Centene by 75.3% in the third quarter. Private Trust Co. NA now owns 773 shares of the company’s stock valued at $58,000 after buying an additional 332 shares during the last quarter. True Wealth Design LLC acquired a new position in shares of Centene during the third quarter valued at $66,000. Venturi Wealth Management LLC grew its position in shares of Centene by 77.3% during the third quarter. Venturi Wealth Management LLC now owns 1,163 shares of the company’s stock worth $88,000 after acquiring an additional 507 shares during the last quarter. Finally, R Squared Ltd acquired a new stake in shares of Centene in the 4th quarter worth about $82,000. Institutional investors and hedge funds own 93.63% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on CNC shares. JPMorgan Chase & Co. restated an “overweight” rating and issued a $75.00 target price (down previously from $80.00) on shares of Centene in a research report on Tuesday, December 17th. Oppenheimer decreased their price objective on Centene from $95.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, December 13th. Wells Fargo & Company cut their target price on Centene from $76.00 to $72.00 and set an “overweight” rating on the stock in a research note on Friday, February 14th. Barclays increased their price target on Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a research note on Friday, December 13th. Finally, Robert W. Baird lifted their price objective on shares of Centene from $66.00 to $71.00 in a research note on Tuesday, February 4th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $79.92.

Centene Trading Up 2.2 %

Shares of NYSE:CNC opened at $58.18 on Friday. The stock has a market capitalization of $28.86 billion, a price-to-earnings ratio of 9.32, a PEG ratio of 0.80 and a beta of 0.45. Centene Co. has a 1-year low of $55.03 and a 1-year high of $80.59. The company has a 50 day moving average price of $61.01 and a 200 day moving average price of $65.38. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.10 and a current ratio of 1.11.

Centene (NYSE:CNC) last issued its earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.49 by $0.31. Centene had a return on equity of 13.85% and a net margin of 2.03%. The business had revenue of $40.81 billion for the quarter, compared to analysts’ expectations of $38.78 billion. During the same period in the previous year, the firm posted $0.45 EPS. The company’s quarterly revenue was up 3.4% on a year-over-year basis. On average, research analysts anticipate that Centene Co. will post 6.86 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Thomas Greco bought 17,000 shares of the company’s stock in a transaction dated Wednesday, December 18th. The shares were acquired at an average cost of $59.75 per share, with a total value of $1,015,750.00. Following the completion of the transaction, the director now directly owns 19,309 shares in the company, valued at approximately $1,153,712.75. The trade was a 736.25 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Theodore R. Samuels II purchased 5,000 shares of Centene stock in a transaction that occurred on Friday, December 13th. The stock was purchased at an average price of $58.86 per share, with a total value of $294,300.00. Following the transaction, the director now owns 23,000 shares in the company, valued at $1,353,780. This represents a 27.78 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have purchased 23,693 shares of company stock worth $1,409,954. Company insiders own 0.33% of the company’s stock.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.